CVR 30723589Private limited company (ApS)Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721900)København KFounded 11 Jul 2007
CVR registers no owner holding 5% or more.
CVR holds no employment figures for this company.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about ENTROP PHARMA ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexCVR registers no owner holding 5% or more.
Florian Schønhartinguntil 13 Feb 2013
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
Not available in the CVR filing: the annual reports carry no machine-readable figures.
Annual report 2011
Published 17 Apr 2012
Annual report 2010
Published 15 May 2011
Annual report 2009
Published 13 Apr 2010
Annual report 2008
11 Jul 2007 to 31 Dec 2008, published 19 Apr 2009
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
What Pro holds for ENTROP PHARMA ApS:
Have Pro? Sign in.
Amounts in DKK.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| FoundingNot read from the announcement | None | None | None | 500,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Source: CVR, read 19 Nov 2026.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 19 Nov 2026.
8 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Likvidation sluttet, og selskabet opløst.
Likvidation vedtaget 13.02.2013.
Tiltrådt som likvidator:
Advokat Jakob Mosegaard Larsen, 1459 København K, den 13.02.2013.
Ledelsen fratrådt.
Selskabet tegnes af likvidator alene.
Selskabets kreditorer opfordres til at anmelde deres krav til likvidator. Krav skal anmeldes senest tre måneder fra dags dato.
Vedtægter ændret:
16.04.2012.
Selskabet er omdannet til et ApS med CVR-nr 30723589.
NAVN: ENTROP PHARMA ApS.
ADRESSE: c/o NB Capital ApS, Østergade 24A, 1. tv., 1100 København K.
Kommune:
København.
Kapital kr. 500.000,00.
Direktion:
Direktør Florian Schønharting, den 16.04.2012.
Selskabet tegnes af den samlede direktion.
Revision:
CVR-NR. 26052394 ERNST & YOUNG P/S, Gyngemose Parkvej 50, 2860 Søborg.
Regnskabsår:
01.01 - 31.12.
Ny adresse:
c/o NB Capital ApS, Østergade 24A, 1. tv., 1100 København K.
Vedtægter ændret:
01.07.2010.
Bestyrelse:
Udtrådt af bestyrelsen:
Cora Louise Madsen, den 21.11.2008.
Indtrådt i bestyrelsen:
Vice President Wyle David Solomon, den 21.11.2008.
Stiftelsesdato:
11.07.2007.
Seneste vedtægtsdato:
11.07.2007.
Kapital:
kr. 500.000,00.
Indbetalingsmåde:
kontant kr. 500.000,00 til kurs 743,17.
Stifter:
CVR-NR. 29150397 NORDIC BIOTECH VENTURE FUND II K/S, Østergade 5, 3., 1100 København K, den 11.07.2007.
Bestyrelse:
Direktør Florian Schønharting (formand), den 11.07.2007, Direktør Christian Karsten Hansen, den 11.07.2007, Direktør Cora Louise Madsen, den 11.07.2007.
Direktion:
Direktør Christian Karsten Hansen, den 11.07.2007.
Selskabet tegnes af to bestyrelsesmedlemmer, et bestyrelsesmedlem i forening med en direktør eller af den samlede bestyrelse.
Revision:
CVR-NR. 73317428 ERNST & YOUNG STATSAUTORISERET REVISIONSAKTIESELSKAB, Tagensvej 86, 2200 København N, den 11.07.2007.
Første regnskabsår:
11.07.2007 - 31.12.2008.
Regnskabsår:
01.01 - 31.12.
P-number 1013472196Østergade 24, 1100 København K